Table 2.
Ref. | Year | Category | Disease (:control) | AUC | Accuracy | Sensitivity | Specificity | Sample No. | Control No. |
Shepherd et al[56] | 2014 | IBD | IBD:IBS | - | - | 76% | 88% | 102 | 135 |
Shepherd et al[56] | 2014 | IBD | IBD | - | - | 79% | - | 135 | 138 |
Cauchi et al[58] | 2014 | IBD | Crohn disease | 0.97 | 85% | 93% | 78% | 24 | 20 |
Cauchi et al[58] | 2014 | IBD | Ulcerative colitis | 0.54 | 58% | 43% | 69% | 19 | 20 |
de Meij et al[45] | 2014 | IBD | Crohn disease, active | 0.85 | - | 86% | 67% | 29 | 28 |
de Meij et al[45] | 2014 | IBD | Crohn disease, remission | 0.94 | - | 94% | 94% | 29 | 28 |
de Meij et al[45] | 2014 | IBD | Ulcerative colitis, active | 1.00 | - | 100% | 100% | 26 | 28 |
de Meij et al[45] | 2014 | IBD | Ulcerative colitis, remission | 0.94 | - | 94% | 94% | 26 | 28 |
de Meij et al[45] | 2014 | IBD | Crohn disease, active:ulcerative colitis, active | 0.96 | - | 97% | 92% | 29 | 26 |
de Meij et al[45] | 2014 | IBD | Crohn disease, remission:ulcerative colitis, remission | 0.81 | - | 88% | 72% | 29 | 26 |
Walton et al[59] | 2013 | IBD | Crohn disease | - | - | - | - | 22 | 19 |
Walton et al[59] | 2013 | IBD | Ulcerative colitis | - | - | - | - | 20 | 19 |
de Meij et al[69] | 2013 | IBD | Crohn disease | 0.98 | - | 92% | 100% | 9 | 10 |
de Meij et al[69] | 2013 | IBD | Ulcerative colitis | 0.75 | - | 75% | 77% | 10 | 10 |
De Preter et al[70] | 2011 | IBD | IBD | - | - | - | - | 11 | 11 |
Garner et al[61] | 2007 | IBD | Ulcerative colitis | - | - | 96% | - | 18 | 30 |
IBD pooled mean: | 0.87 | 72% | 86% | 85% | - | - |
If no control is specified, the comparison is against a healthy control. IBD: Inflammatory bowel disease; IBS: Irritable bowel syndrome; AUC: Area under the curve.